Association of Oseltamivir Treatment With Virus Shedding, Illness, and Household Transmission of Influenza Viruses.
Level III
Where this comes from
- Record sourced from PubMed, PMID 25646354.
- Also identified by DOI 10.1093/infdis/jiv058 and PMC identifier 4866553.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In an observational study of 582 patients with laboratory-confirmed influenza virus infections and their household contacts, we found that the initiation of oseltamivir within 24 hours was associated with shorter duration of self-reported illness symptoms (56% reduction in duration; 95% confidence interval, 41%-67%). However, we did not find any association of oseltamivir treatment with duration of viral shedding by polymerase chain reaction or with the risk of household transmission.
Medical subject headings
- Antiviral Agents
- Influenza, Human
- Orthomyxoviridae
- Oseltamivir
- Virus Shedding